Life sciences software & AI news

Showing 1000+ results

Nov 4, 2026

Circular Genomics and PharmatrophiX Announce Strategic Collaboration to Advance circRNA Biomarkers in Neurodegenerative Drug Development

Collaboration will initially apply blood-based circular RNA profiling to LM11A-31 in Alzheimer's disease, with potential expansion across PharmatrophiX's neurodegeneration pipelineSAN DIEGO and MENLO PARK, Calif., Nov. 4, 2026 /PRNewswire/ -- Circular Genomics, Inc., a precision neurology company developing circular RNA (circRNA)-based biomarkers, and PharmatrophiX, Inc., a clinical-stage biopharmaceutical company developing disease-modifying therapies for neurodegenerative diseases, today annou

Nov 4, 2026

Press release

Cognixion Now Enrolling NIH-Funded Study of Wearable Brain-Computer Interface Communication Device for People with ALS

First of its kind, longitudinal clinical study comparing Cognixion's investigational Brain Computer Interface (BCI) with the Market leading eye-tracking communication devices people with ALS currently rely upon for daily communicationSANTA BARBARA, Calif., Nov. 4, 2026 /PRNewswire/ -- Cognixion Corporation today announced that it is now enrolling participants in the CHOICE study, a research study of a wearable brain–computer interface (BCI) communication device for people living with amyotrophic

A test tube containing a clinical sample on a lab bench with equipment in the background.

Nov 4, 2026

nPhase rakes in $30M to expand AI-native clinical data platform

nPhase has successfully secured $30 million in a Series D funding round to enhance its AI-driven clinical data platform, nPhase.ai, which aims to streamline the clinical data lifecycle from study initiation to regulatory submission.The latest financing, spearheaded by Viking Global Investors, is nPhase's first since 2017. The funding will facilitate the expansion of the platform's capabilities, particularly its agentic AI features that aim to transform data management into intelligent workflows.

Nov 4, 2026

Press release

Sectra Reporting brings imaging, AI, and radiology reporting together in one system at Mount Sinai Health System

LINKÖPING, Sweden, Nov. 4, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed an agreement with Mount Sinai Health System in New York to deliver Sectra Reporting, the native reporting module in Sectra's enterprise imaging solution, Sectra One Cloud. Mount Sinai's radiologists will go from worklist to signed report in one seamless experience, without switching between systems, helping shorten report turnaround times."Radiologists read t

A minimalist illustration of a human jaw and tooth in flat design.

Nov 4, 2026

Leipzig-based JawBuddy raises €818k to help people reduce jaw pain, bruxism, and TMJ-related tension

Leipzig's JawBuddy has successfully secured €818k in pre-Seed funding to advance its innovative approach to alleviating jaw pain, bruxism, and TMJ-related tension.The funding round was led by HALBZEIT, a healthcare platform, and included contributions from notable figures in dentistry such as Dr. Siegfried Marquardt and Dr. Guido Sigron, along with various investors and business angels. This financial boost is intended to facilitate the startup's clinical trials and pave the way for reimbursemen

A syringe and vial in a dimly lit lab setting, emphasizing human oversight in AI applications.

Nov 4, 2026

What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI

Europe's draft Annex 22 outlines critical guidelines for human oversight in AI applications within the pharmaceutical sector, emphasizing the need for rigorous human review processes in GMP operations.The draft, under consultation until October 2025, specifically addresses AI models that affect patient safety and product quality. It categorically states that certain AI types, like generative models, should not be employed in critical applications. Instead, it mandates that qualified personnel ov

Nov 4, 2026

Press release

UCB advances its digital antibody engineering program with new Cradle collaboration

Collaboration adds Cradle's end-to-end platform to UCB's computational capabilities, supporting faster discovery of complex therapies for severe diseasesBRUSSELS and AMSTERDAM, Nov. 4, 2026 /PRNewswire/ -- UCB, a global biopharmaceutical company, and Cradle, which builds a leading AI-driven protein design and engineering platform, today announced a strategic collaboration. The collaboration is the latest step in UCB's expanding digital antibody discovery and engineering program, which draws on t

Nov 4, 2026

Press release

Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine

Alamar’s NULISAseq™ Immune 340 and NULISAseq™ Neuro 220 panels will be used to investigate disease progression, biological subtypes and treatment responseFREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced a strategic scientific collaboration with GSK plc (LSE/NYSE: GSK) that will use Alamar’s NULISA™ platform in a large-scale study examining how ci

Nov 4, 2026

Press release

TXP Medical Publishes Whitepaper "The State of Japanese Real-World Evidence," Analyzing the Current State of Real-World Evidence (RWE) in Japan

～ EMR-derived data market to grow from approx. ¥3.9 billion (2025) to approx. ¥25 billion (2035) ～～ RWD/RWE use in new approvals up from 18.1% (2019) to 30.4% (2024) ～～ Claims/DPC and EMR data: complementary roles clarified for Medical Affairs ～TOKYO, Nov. 3, 2026 /PRNewswire/ -- TXP Medical Co., Ltd. (Representative Director and CEO: Tomohiro Sonoo; "TXP Medical") has published the Whitepaper "The State of Japanese Real-World Evidence," a comprehensive analysis of how real-world data (RWD) and

A pipette and test tube representing precision automation in biology

Nov 3, 2026

Precision Automation Meets Biology

Precision automation is transforming cell-based research by enhancing consistency and reducing variability in laboratory settings.In the realm of cell-based research, the integration of automation technologies is proving invaluable. While high-throughput capabilities are often highlighted, the primary benefits lie in minimizing repetitive tasks, controlling experimental variability, and enhancing overall consistency. These advantages are crucial, as even minor manual errors can significantly aff

Nov 3, 2026

Press release

Cerbo Expands AI Scribe to Virtual Visits, Bringing Native AI Charting to Telehealth

AI Scribe now drafts the structured note inside the chart for Cerbo Telemedicine and Zoom visits, so telehealth doesn't mean extra time spent on documentation.ATLANTA, Nov. 3, 2026 /PRNewswire/ -- Cerbo, a leading electronic health record (EHR) platform forcash pay, personalized care practices, today announced that AI Scribe, its native clinical documentation tool, now works on virtual visits. AI Scribe captures the conversation on native Telemedicine and Zoom visits, then drafts a structured no

Nov 3, 2026

Press release

How the NIH Common Fund Data Ecosystem Could Accelerate Scientific Discovery

CU Anschutz researchers play a major role in evaluating research data from 18 programs to help scientists uncover relationships across studies and make better use of existing research.AURORA, Colo., Nov. 3, 2026 /PRNewswire/ -- Scientists generate vast amounts of research data, but connecting information across studies can be difficult. The NIH Common Fund Data Ecosystem is working to change that by making research datasets from 18 NIH programs easier to find, connect and analyze.The initiative

Back to start
Previous
Page 3 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Domains

Services

Legal